231 related articles for article (PubMed ID: 2291005)
1. [Biology and differentiation of lymphocytes in the classification of lymphomas].
Mariuzzi G; Di Loreto C; Mariuzzi L
Recenti Prog Med; 1990 Oct; 81(10):621-8. PubMed ID: 2291005
[TBL] [Abstract][Full Text] [Related]
2. [Histopathology of malignant lymphomas].
Yamabe H
Rinsho Byori; 1990 Apr; 38(4):386-9. PubMed ID: 2195192
[TBL] [Abstract][Full Text] [Related]
3. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
Meusers P; Brittinger G
Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
[TBL] [Abstract][Full Text] [Related]
5. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
Carbone A; Gloghini A; Gruss HJ; Pinto A
Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
[TBL] [Abstract][Full Text] [Related]
6. Hodgkin and Reed-Sternberg cell associated monoclonal antibodies HRS-1 and HRS-2 react with activated cells of lymphoid and monocytoid origin.
Pfreundschuh M; Mommertz E; Meissner M; Feller AC; Hassa R; Krueger GR; Diehl V
Anticancer Res; 1988; 8(2):217-24. PubMed ID: 3364933
[TBL] [Abstract][Full Text] [Related]
7. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.
Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A
J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotypic analysis of non-Hodgkin's lymphomas.
La Via MF; Self SE
Recenti Prog Med; 1990 Oct; 81(10):629-34. PubMed ID: 2291006
[TBL] [Abstract][Full Text] [Related]
9. [Pathology of Hodgkin's lymphoma].
Hansmann ML; Willenbrock K
Verh Dtsch Ges Pathol; 2003; 87():53-7. PubMed ID: 16888894
[TBL] [Abstract][Full Text] [Related]
10. Immunological markers in non-Hodgkin's lymphomas.
Gobbi M; Mazza P; Mantovani W; Fiacchini M; Lauria F; Tura S
Boll Ist Sieroter Milan; 1979 Nov; 58(5):410-5. PubMed ID: 399843
[TBL] [Abstract][Full Text] [Related]
11. [Recent views on the functional histological classification of malignant lymphomas].
Guarino M; Caldara G
Arch Sci Med (Torino); 1975; 132(1):1-8. PubMed ID: 1080409
[TBL] [Abstract][Full Text] [Related]
12. [The origin and clonal proliferation of malignant altered cells in Hodgkin's disease].
Krizanac-Bengez L; Boranic M
Lijec Vjesn; 1990; 112(1-2):50-2. PubMed ID: 2366621
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of immunophenotype in aggressive non-Hodgkin's lymphoma.
Tsartsidze E; Betaneli M
Georgian Med News; 2006 May; (134):107-9. PubMed ID: 16783081
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
Nguyen PL; Harris NL; Ritz J; Robertson MJ
Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
[TBL] [Abstract][Full Text] [Related]
15. Two monoclonal antibodies defining unique antigenic determinants on human B-lymphoma cells.
Howard DR; Eaves AC; Takei F
Cancer Res; 1985 Dec; 45(12 Pt 1):6322-7. PubMed ID: 2415242
[TBL] [Abstract][Full Text] [Related]
16. [Pathohistology of non-Hodgkin's lymphomas: recent progress].
Kelényi G
Z Gesamte Inn Med; 1979 Jul; 34(13):162-6. PubMed ID: 317195
[TBL] [Abstract][Full Text] [Related]
17. Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker.
Pinkus GS; Said JW
Am J Pathol; 1988 Nov; 133(2):211-7. PubMed ID: 3263805
[TBL] [Abstract][Full Text] [Related]
18. IL-2 receptor expression in human lymphoid lesions. Immunohistochemical study of 166 cases.
Strauchen JA; Breakstone BA
Am J Pathol; 1987 Mar; 126(3):506-12. PubMed ID: 3103454
[TBL] [Abstract][Full Text] [Related]
19. Application of a T cell receptor antibody beta F1 for immunophenotypic analysis of malignant lymphomas.
Ng CS; Chan JK; Hui PK; Chan WC; Lo ST
Am J Pathol; 1988 Aug; 132(2):365-71. PubMed ID: 2456701
[TBL] [Abstract][Full Text] [Related]
20. [The morphological diagnosis of malignant non-Hodgkin's lymphomas (lymphosarcomas)].
Probatova NA
Arkh Patol; 1990; 52(9):72-5. PubMed ID: 2270988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]